Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.70 |
| ▸ | P2RX4 | Q99571 | 2/20 | 0.56 |
| ▸ | CNR2 | P34972 | 1/20 | 0.56 |
| ▸ | MAOA | P21397 | 4/20 | 0.50 |
| ▸ | MAOB | P27338 | 4/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.50 |
| ▸ | KCNK13 | Q9HB14 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13957035 | 0.85 | CYP19A1 (0.86) | CYP19A1P2RX4HDAC6HDAC1HDAC10 | |
| SCHEMBL2216252 | 0.84 | CYP19A1 (0.70) | CYP19A1P2RX4MAOAMAOBHDAC6 | |
| SCHEMBL151053 | 0.83 | CYP19A1 (1.00) | CYP19A1P2RX4HDAC6HDAC1HDAC10 | |
| SCHEMBL30007452 | 0.83 | CYP19A1 (1.00) | CYP19A1P2RX4HDAC6HDAC1HDAC10 | |
| SCHEMBL13866635 | 0.81 | MAOA (0.60) | CYP19A1P2RX4MAOAMAOBHDAC6 | |
| Bromide SCHEMBL28888744 | 0.81 | CYP19A1 (0.95) | CYP19A1P2RX4HDAC6HDAC1HDAC10 | |
| Ammonia Solution, Strong SCHEMBL29210102 | 0.81 | CYP19A1 (0.95) | CYP19A1P2RX4HDAC6HDAC1HDAC10 | |
| SCHEMBL9398256 | 0.81 | CYP19A1 (0.95) | CYP19A1P2RX4HDAC6HDAC1HDAC10 | |
| SCHEMBL25382673 | 0.79 | HDAC6 (0.57) | CYP19A1MAOAMAOBHDAC6HDAC1 | |
| SCHEMBL1716066 | 0.79 | MIF (0.51) | CYP19A1P2RX4CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190296247-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190296247-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SLC25A21, SLCO4C1, SLC18A1 | CYP19A1 1852/4885P2RX4 641/4885CNR2 3596/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.